Silk Road Medical, Inc (NASDAQ:SILK) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Silk Road Medical Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Silk Road Medical Inc (SILK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 977,961 | $14,659,636 | -12% | 0.02% |
| 2. | Citadel Investment Group Ken Griffin | 618,107 | $9,265,424 | +1496% | 0% |
| 3. | Tri Locum Partners Prashanth Jayaram | 536,392 | $8,040,516 | +171% | 2.57% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 424,500 | $6,363,255 | +51% | 0.01% |
| 5. | Parkman Healthcare Partners Greg Martinez | 249,341 | $3,737,622 | -19% | 0.68% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.30 | 2,500 | 132,179 | 2021-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.61 | 656 | 54,941 | 2023-10-27 | Filing | ||
| $15.22 | 2,662 | 435,848 | 2023-10-04 | Filing | ||
| $56.62 | 1,651 | 267,988 | 2021-03-02 | Filing | ||
| $20.11 | 1,539 | 38,797 | 2023-08-17 | Filing | ||
| $22.13 | 6,587 | 109,534 | 2023-08-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,707,673 | $85,558,018 | 0.54% | |
| 2. | 3,576,501 | $53,611,751 | 0% | |
| 3. | 2,966,730 | $44,471,283 | 0% | |
| 4. | 2,921,169 | $43,788,324 | 0% | |
| 5. | 1,725,913 | $25,871,434 | 0.02% |
News See All
Here’s Why Silk Road Medical (SILK) Detracted in Q3
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Silk Road Medical, Inc (NASDAQ:SILK) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for joining Silk Road Medical's Second Quarter 2023 Earnings Call.
Silk Road Medical, Inc (NASDAQ:SILK) Q1 2023 Earnings Call Transcript
Operator: Good day. Thank you for standing by. Welcome to the Silk Road Medical's 2023 First Quarter Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Here’s Why Silk Road Medical (SILK) Declined in Q1
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Silk Road Medical, Inc (NASDAQ:SILK) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2022 Silk Road Medical Conference Call. At this time, all participants are in a listen-only mode.
Silk Road Medical, Inc (NASDAQ:SILK) Q3 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Silk Road Medical 2022 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Is Silk Road Medical (SILK) a Great Stock to Invest in?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small/Mid Cap Growth Strategy” third-quarter investor letter.
Here's What Makes Silk Road Medical (SILK) a Strong Stock
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Ultra Strategy” third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Will the Label Update Accelerate the Growth of Silk Road Medical (SILK)?
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
